Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TANDEM DIABETES CARE INCTNDM · Entity 4682 | EVP & Chief Admin. Officer | August 15, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TANDEM DIABETES CARE INC
Report date August 15, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,788 |
Ending reported balance
After 2026-08-15 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-08-15 · Exercise / conversion · Acquired 1,097 · Balance 51,867 Row 2 · 2026-08-15 · Tax withholding · Disposed 314 · Balance 51,553 F1: Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold. Row 3 · 2026-08-15 · Exercise / conversion · Acquired 1,730 · Balance 53,283 Row 4 · 2026-08-15 · Tax withholding · Disposed 495 · Balance 52,788 F1: Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 3,290 |
Reported balance
After 2026-08-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-08-15 · Exercise / conversion · Disposed 1,097 · Balance 3,290 F2: Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F3: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F4: One-third of the RSUs granted on May 23, 2024 vested on May 15, 2025, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 12,115 |
Reported balance
After 2026-08-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-08-15 · Exercise / conversion · Disposed 1,730 · Balance 12,115 F5: Awarded on May 30, 2025 pursuant to the 2023 Plan. F3: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F6: One-third of the RSUs granted on May 30, 2025 vested on May 15, 2026, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold.
F2: Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
F3: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
F4: One-third of the RSUs granted on May 23, 2024 vested on May 15, 2025, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.
F5: Awarded on May 30, 2025 pursuant to the 2023 Plan.
F6: One-third of the RSUs granted on May 30, 2025 vested on May 15, 2026, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 28, 2020 Filed Sep 1, 2020 21:19 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 7,522 | $0.00 Strike: $18.86 | $0.00 |
DisclosureSEC source: 0001438133-20-000134 · wf-form4_159899515925296.xml · derivative · entry 7 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,478 Underlying: Common Stock · 7,522 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to fifty percent (50%) of the underlying shares on 06/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter. F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| August 28, 2020 Filed Sep 1, 2020 21:19 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 7,522 | $114.00 | $857,508.00 |
DisclosureSEC source: 0001438133-20-000134 · wf-form4_159899515925296.xml · nonDerivative · entry 2 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,256 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2020. Read SEC document |
| August 28, 2020 Filed Sep 1, 2020 21:19 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 7,522 | $18.86 | $141,864.92 |
DisclosureSEC source: 0001438133-20-000134 · wf-form4_159899515925296.xml · nonDerivative · entry 1 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| July 31, 2020 Filed Aug 5, 2020 00:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 20,000 | $0.00 Strike: $18.86 | $0.00 |
DisclosureSEC source: 0001438133-20-000124 · wf-form4_159658634151927.xml · derivative · entry 10 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 20,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The option vested as to fifty percent (50%) of the underlying shares on 06/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter. F10 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| July 31, 2020 Filed Aug 5, 2020 00:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 30,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001438133-20-000124 · wf-form4_159658634151927.xml · derivative · entry 9 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares vested in twelve (12) equal monthly installments thereafter. F10 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| July 31, 2020 Filed Aug 5, 2020 00:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,270 | $110.59 | $140,448.03 |
DisclosureSEC source: 0001438133-20-000124 · wf-form4_159658634151927.xml · nonDerivative · entry 8 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,256 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 10, 2018. F8 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $110.50 to $110.67. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| July 31, 2020 Filed Aug 5, 2020 00:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 10,213 | $109.79 | $1,121,269.95 |
DisclosureSEC source: 0001438133-20-000124 · wf-form4_159658634151927.xml · nonDerivative · entry 7 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,526 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 10, 2018. F7 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $109.50 to $110.36. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| July 31, 2020 Filed Aug 5, 2020 00:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 15,001 | $108.91 | $1,633,818.91 |
DisclosureSEC source: 0001438133-20-000124 · wf-form4_159658634151927.xml · nonDerivative · entry 6 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,739 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 10, 2018. F6 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $108.48 to $109.47. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| July 31, 2020 Filed Aug 5, 2020 00:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 18,672 | $108.06 | $2,017,672.05 |
DisclosureSEC source: 0001438133-20-000124 · wf-form4_159658634151927.xml · nonDerivative · entry 5 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,740 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 10, 2018. F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $107.43 to $108.43. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| July 31, 2020 Filed Aug 5, 2020 00:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 2,894 | $106.94 | $309,470.18 |
DisclosureSEC source: 0001438133-20-000124 · wf-form4_159658634151927.xml · nonDerivative · entry 4 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,412 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 10, 2018. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $106.36 to $107.35. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| July 31, 2020 Filed Aug 5, 2020 00:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,950 | $105.85 | $206,400.68 |
DisclosureSEC source: 0001438133-20-000124 · wf-form4_159658634151927.xml · nonDerivative · entry 3 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,306 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 10, 2018. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $105.22 to $106.17. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| July 31, 2020 Filed Aug 5, 2020 00:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 20,000 | $18.86 | $377,200.00 |
DisclosureSEC source: 0001438133-20-000124 · wf-form4_159658634151927.xml · nonDerivative · entry 2 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| July 31, 2020 Filed Aug 5, 2020 00:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 30,000 | $2.59 | $77,700.00 |
DisclosureSEC source: 0001438133-20-000124 · wf-form4_159658634151927.xml · nonDerivative · entry 1 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| May 27, 2020 Filed May 30, 2020 00:45 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Option · Derivative | 15,012 | $0.00 Strike: $82.34 | $0.00 |
DisclosureSEC source: 0001438133-20-000073 · wf-form4_159079950739711.xml · derivative · entry 2 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,012 Underlying: Common Stock · 15,012 shares Expires not disclosed F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F4 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on the one year anniversary of the grant date, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan. F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| May 27, 2020 Filed May 30, 2020 00:45 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 6,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-20-000073 · wf-form4_159079950739711.xml · derivative · entry 1 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,504 Underlying: Common Stock · 6,504 shares Expires not disclosed F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| May 15, 2020 Filed May 20, 2020 00:36 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantCommon Stock | 1,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-20-000057 · wf-form4_158993495580069.xml · nonDerivative · entry 1 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,256 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2019 through May 15, 2020. This transaction is also exempt under Rule 16b-3(c). Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantCommon Stock | 1,256 | $16.93 | $21,264.08 |
DisclosureSEC source: 0001209191-19-030981 · doc4.xml · nonDerivative · entry 1 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,001 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2018 through May 15, 2019. This transaction is also exempt under Rule 16b-3(c). Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 1,282 | $0.00 Strike: $11.06 | $0.00 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · derivative · entry 10 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,145 Underlying: Common Stock · 1,282 shares Expires 2023-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The date of the option was 4/23/2013. All shares subject to the option vest in 24 equal monthly installments commencing on 4/23/2013. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 4,121 | $0.00 Strike: $11.06 | $0.00 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · derivative · entry 9 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,121 shares Expires 2023-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The date of the option was 4/23/2013. All shares subject to the option vest in 24 equal monthly installments commencing on 4/23/2013. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 4,597 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · derivative · entry 8 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,903 Underlying: Common Stock · 4,597 shares Expires 2027-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty five percent (25%) of the underlying shares subject to the option vested on 05/17/2018, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 50,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · derivative · entry 7 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 50,000 shares Expires 2027-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 25,354 | $68.39 | $1,733,960.06 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · nonDerivative · entry 6 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,745 F2 · price: The price reported reflects the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2018, in multiple transactions at prices ranging from $68.00 to $68.89. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 34,646 | $67.35 | $2,333,408.10 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · nonDerivative · entry 5 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,099 F1 · price: The price reported reflects the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2018, in multiple transactions at prices ranging from $67.00 to $67.99. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,282 | $11.06 | $14,177.64 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · nonDerivative · entry 4 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 4,121 | $11.06 | $45,574.14 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · nonDerivative · entry 3 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 4,597 | $9.00 | $41,373.00 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · nonDerivative · entry 2 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 50,000 | $2.59 | $129,500.00 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · nonDerivative · entry 1 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 21:08 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Option · Derivative | 105,000 | $0.00 Strike: $51.50 | $0.00 |
DisclosureSEC source: 0001209191-19-011500 · doc4.xml · derivative · entry 1 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 23:25 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantCommon Stock | 1,255 | $16.92 | $21,234.60 |
DisclosureSEC source: 0001209191-18-059308 · doc4.xml · nonDerivative · entry 1 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,745 F1 · date: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of June 15, 2018 through November 15, 2018. This transaction is also exempt under Rule 16b-3(c). F2 · date: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 15, 2018. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 22:49 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Options · Derivative | 100,000 | $0.00 Strike: $18.86 | $0.00 |
DisclosureSEC source: 0001209191-18-038168 · doc4.xml · derivative · entry 1 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest as to 50% on 6/14/2019 and the remainder in 12 equal monthly installments thereafter F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:59 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Option · Derivative | 80,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-17-064032 · doc4.xml · derivative · entry 1 Morrison Susan · CIK 0001582970 · CHIEF ADMINSTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| May 17, 2017 Filed May 18, 2017 21:04 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Options · Derivative | 105,000 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001209191-17-033636 · doc4.xml · derivative · entry 2 Morrison Susan · CIK 0001582970 · CHIEF ADMINSTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires not disclosed F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F4 · derivative.exercise_date: All shares subject to the option will vest as to 25% on 5/17/2018 and the remainder in 36 equal monthly installments thereafter. F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| May 15, 2017 Filed May 18, 2017 21:04 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantCommon Stock | 12,501 | $0.77 | $9,625.77 |
DisclosureSEC source: 0001209191-17-033636 · doc4.xml · nonDerivative · entry 1 Morrison Susan · CIK 0001582970 · CHIEF ADMINSTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,900 F1 · date: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2016 through May 15, 2017. This transaction is also exempt under Rule 16b-3(c). F2 · date: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on May 15, 2017. Read SEC document |
| December 16, 2016 Filed Dec 17, 2016 01:41 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Options · Derivative | 169,200 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001209191-16-155752 · doc4.xml · derivative · entry 1 Morrison Susan · CIK 0001582970 · CHIEF ADMINSTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,200 Underlying: Common Stock · 169,200 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest as to 50% on 12/16/2017 and the remainder in 12 equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.